Dr. Aldape is a globally recognized molecular neuropathologist and Chief of the National Cancer Institute (NCI) Lab of Pathology.  A leading figure in his field, he is esteemed for his influential work using methylation patterns for the sub-classification of brain tumors, now considered the gold standard for diagnosis.

Dr. Aldape’s career has been marked by leadership and innovation. He has held prestigious faculty positions at the University of California, San Francisco, MD Anderson Cancer Center (where he served as department chair of pathology), and Princess Margaret Cancer Centre (as a senior scientist).

Throughout his career, he has remained at the forefront of using molecular technologies to advance precision tumor diagnostics, with over 300 publications to date.